ID   9.6
AC   CVCL_A9EB
SY   HB 9.6
DR   CCRID; 4201PAT-CCTCC00044
DR   Wikidata; Q108819784
RX   Patent=US6010902;
RX   PubMed=6190907;
RX   PubMed=6969782;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10267.
CC   Monoclonal antibody isotype: IgG2a (Patent=US6010902); IgG2b (PubMed=6969782).
CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
RX   Patent=US6010902;
RA   Ledbetter J.A., Gilliland L.K.;
RT   "Antibody heteroconjugates and bispecific antibodies for use in
RT   regulation of lymphocyte activity.";
RL   Patent number US6010902, 04-Jan-2000.
//
RX   PubMed=6190907; DOI=10.4049/jimmunol.131.1.180;
RA   Martin P.J., Longton G., Ledbetter J.A., Newman W., Braun M.P.,
RA   Beatty P.G., Hansen J.A.;
RT   "Identification and functional characterization of two distinct
RT   epitopes on the human T cell surface protein Tp50.";
RL   J. Immunol. 131:180-185(1983).
//
RX   PubMed=6969782; DOI=10.1084/jem.153.1.207;
RA   Kamoun M., Martin P.J., Hansen J.A., Brown M.A., Siadak A.W.,
RA   Nowinski R.C.;
RT   "Identification of a human T lymphocyte surface protein associated
RT   with the E-rosette receptor.";
RL   J. Exp. Med. 153:207-212(1981).
//